Found 801 clinical trials
Sternal Cerclage (sternal bone closure after open heart surgery)
The purpose of the study is to learn which treatment option is better for patients who have multi-vessel coronary artery disease (blockages in more than one vessel supplying blood to the heart muscle).
- 1647 views
- 05 Feb, 2021
- 1 location
Do you have heart disease or diabetes? Lowering cholesterol lowers risk of heart attack or stroke.
Do you have heart disease or diabetes? Lowering cholesterol lowers risk of heart attack or stroke.
- 334 views
- 08 Nov, 2020
- 2 locations
EX9924-4473: Semaglutide cardiovascular outcomes trial in patients with type 2 diabetes (SOUL)
Oral Semaglutide
- 169 views
- 23 Nov, 2020
- 1 location
A Clinical Trial for individuals suffering from Hyperlipidemia (high cholesterol) and are at risk of cardiovascular events (ie: heart attack, stroke, angina.
A Clinical Trial for individuals suffering from Hyperlipidemia (high cholesterol) and are at risk of cardiovascular events (ie: heart attack, stroke, angina.
- 680 views
- 23 Nov, 2020
- 1 location
TAKEDA EXAMINE trial patients for who have Type II diabetes & ACS coronary artery disease, post angiogram or heart attack. This is a phase 3b study. Currently open for enrollment.
TAKEDA EXAMINE trial patients for who have Type II diabetes & ACS coronary artery disease, post angiogram or heart attack. This is a phase 3b study. Currently open for enrollment.
- 300 views
- 08 Nov, 2020
- 1 location
A multinational, randomized, double-blind, placebo controlled trial to evaluate the effect of Ticagrelor 90mg twice daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Stroke in Patients with Type 2 Diabetes Mellitus.
A multinational, randomized, double-blind, placebo controlled trial to evaluate the effect of Ticagrelor 90mg twice daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Stroke in
- 70 views
- 23 Nov, 2020
- 1 location
DECLARE -Dapagliflozin Effect on CardiovascuLAR Events - A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Dapagliflozin 10 mg Once Daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischemic Stroke in Patients with Type 2 Diabetes
Cardiovascular Death, Myocardial Infarction or Ischemic Stroke in Patients with Type 2 Diabetes
- 164 views
- 25 Mar, 2021
- 1 location
A randomized, double-blind, placebo-controlled multicenter trial, assessing the impact of inclisiran on major adverse cardiovascular events in participants with established cardiovascular disease
risks of Cardiovascular Disease such as heart attacks and strokes.
- 0 views
- 29 Apr, 2022
- 1 location
Pilot Study to Evaluate the Effect of Nicotinamide Riboside on Skeletal Muscle Function in Heart Failure Subjects
Background: People are living longer and are more likely to survive a heart attack if they have one. Longer life expectancy is good but it also means more people get
- 311 views
- 09 Apr, 2019
- 1 location
ODYSSEY OUTCOME STUDY - A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome
ODYSSEY OUTCOME STUDY - A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome
- 100 views
- 25 Mar, 2021
- 1 location